Mehta, Parinda A <br/><br/>
Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.  [electronic resource] 

 -  Blood  04 2017 
 - 2308-2315 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2016-09-743112  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antilymphocyte Serum--therapeutic use<br/>Bone Marrow--drug effects<br/>Busulfan--therapeutic use<br/>Child<br/>Child, Preschool<br/>Cyclophosphamide--therapeutic use<br/>Fanconi Anemia--immunology<br/>Female<br/>Graft vs Host Disease--immunology<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Lymphocyte Depletion<br/>Male<br/>Myeloablative Agonists--therapeutic use<br/>Myelodysplastic Syndromes--immunology<br/>Prospective Studies<br/>Siblings<br/>Survival Analysis<br/>T-Lymphocytes--immunology<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Unrelated Donors<br/>Vidarabine--analogs & derivatives